Top 5 Clean Energy Stocks For 2019

Ive been right about Tesla (NASDAQ:TSLA) thus far.

There seem to be only two schools on Tesla. You either love the carmaker, or you hate it with a passion. I fall into the latter category, not because I’m anti clean energy, or opposed to new entries to the auto industry, but because of the grandiose and inefficient management history the company has had under Elon Musk. Ive written often about the competition and general cutthroat nature of the auto industry that Tesla faces. Ive been waiting for some time to see signs of Teslas inability to ramp up car production in a way that justifies its wild stock valuation. And boy howdy have I taken some flak in the comments section.

This week has given me some vindication on my feelings about Tesla. The stock is down on rough news of production complications, and a fading faith in Elon Musks rhetoric, something I said would happen. The valuation is not justified, and cannot be justified when youre selling such a small amount of cars and not turning any profit. I get it that this stock performance is about future potential earnings, but the company is not putting together concrete evidence that it is working toward those types of numbers.

Top 5 Clean Energy Stocks For 2019: Industrias Bachoco, S.A. de C.V.(IBA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Bachoco (NYSE:IBA) declared a semiannual dividend on Thursday, April 26th, NASDAQ reports. Stockholders of record on Friday, May 11th will be given a dividend of 0.432 per share on Monday, May 21st. This represents a dividend yield of 1.53%. The ex-dividend date is Thursday, May 10th. This is a boost from Bachoco’s previous semiannual dividend of $0.42.

Top 5 Clean Energy Stocks For 2019: H&E Equipment Services Inc.(HEES)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of United Rentalsgiving a similar performance but alsopulling away fromsmall cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

Top 5 Clean Energy Stocks For 2019: Escalade, Incorporated(ESCA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Escalade (NASDAQ: ESCA) and Sports Direct Intl (OTCMKTS:SDISY) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Top 5 Clean Energy Stocks For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 5 Clean Energy Stocks For 2019: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get AXT alerts:

    Gallium Arsenide Global Market Players by 2023- Sumitomo Electric, AXT and China Crystal Technologies (newspharmaceuticals.com) TheStreet Downgrades AXT (AXTI) to C+ (americanbankingnews.com) Is this stock is Overbought? AXT, Inc. (AXTI) (stockquote.review) What Investors Should Know? AXT, Inc. (AXTI) (mostvolatilestocks.com) Community rallies around valley high school, putting on its first musical in 20 years (yourcentralvalley.com)

    Several analysts have recently issued reports on AXTI shares. BidaskClub upgraded AXT from a “hold” rating to a “buy” rating in a research note on Wednesday, February 14th. Dougherty & Co reiterated a “buy” rating on shares of AXT in a research note on Thursday, February 22nd. B. Riley decreased their price target on AXT from $8.75 to $8.25 and set a “neutral” rating for the company in a research note on Thursday, February 22nd. Zacks Investment Research downgraded AXT from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Finally, BWS Financial restated a “buy” rating on shares of AXT in a research note on Tuesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $10.44.